帕金森病的运动症状受到温度的影响:一项受控试点研究
Ting Huang1, Xi-Xi Wang1, Chen-Yu Gao2,3
1Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Brain and behavior
|February 20, 2024
概括
季节性变化会影响帕金森病的运动症状. 高热浴 (HTB) 可以暂时改善像布拉迪基尼西亚和刚性这样的症状,这表明HTB是温度敏感PD患者的潜在物理治疗.
科学领域:
- 神经学 神经学
- 物理疗法物理治疗
背景情况:
- 帕金森病 (PD) 的运动症状 (MS) 影响患者的生活质量.
- 患者经常在冬季报告MS恶化,过热浴 (HTB) 暂时缓解.
研究的目的:
- 评估季节性温度变化对PD运动症状的影响.
- 评估高热浴 (HTB) 对改善帕金森病患者运动症状的有效性.
主要方法:
- 对203名中国汉族PD患者进行横截面研究.
- 季节变化因子的单变量和多变量分析.
- 在10名受试者中,对MDS-UPDRS第三部分和韦伯斯特症状评分对HTB影响进行了配对威尔科克森排名测试.
主要成果:
- 在HTB后MS的改善是季节性变化的重要独立风险因素 (OR 25.203).
- 患有PD的患者在MDS-UPDRS第三部分得分中显著改善,特别是在HTB后的布拉迪基尼西亚,刚性,姿势和休息震幅度.
结论:
- 季节性和HTB水温可能会影响PD运动症状.
- 对于患有温度敏感性MS的PD患者,HTB可以被推作为物理治疗干预措施.
相关概念视频
Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Decreased Body Temperature
616
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
616
Parkinson's Disease: Overview
546
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
546


